Nine hundred and eleven patients were admitted to a multicentre trial with bacampicillin (Penglobe®) in respiratory tract infections. Of these it was possible to evaluate 830 with respect to efficacy and side-effects. In most cases a dosage of 400 mg × 2 was used but in severe cases 800 mg × 2 was used. The clinical outcome was assessed as good for 79% of the patients, while 17% showed an improvement and 3% a failure. The tolerance was good with an over-all incidence of 8% side-effects, of which dyspepsia was the most common.
Get full access to this article
View all access options for this article.
References
1.
DaviesB IMaesenF P V (1978) Ampicillin and bacampicillin in chronic bronchitis. In: SiegenthalerELuethyR, (Eds), Current Chemotherapy I, Proceedings of the 10th International Congress of Chemotherapy, Zürich 1977. American Society for Microbiology, Washington p 622.
2.
EkströmBForsgrenUMagniLSjöbergBSjövallJTolfR (1977) Bacampicillin, a well-absorbed pro-drug of ampicillin — a report on properties and clinical experiences. Journal of Drug Research2, 39.
3.
HallanderH OFlodströmASjövallJ (1977) Pharmacological and clinical study of bacampicillin in acute peritonsillitis — a comparison with ampicillin. Antimicrobial Agents and Chemotherapy11, 185.
4.
NordbringF (1979) Review of side-effects of aminopenicillins. Infection7, (Suppl. 5), 503.
5.
OlssonOHenningC (1976) Clinical study on bacampicillin in otitis media acuta and sinusitis acuta. In: WilliamsJ DGeddesA M, (Eds), Chemotherapy 5, Penicillins and cephalosporins. Plenum Press, New York145.
6.
RaunioVJokinenKKarjalainenS (1976) Clinical, bacteriological, and pharmacological study of bacampicillin in chronic maxillary sinusitis. In: WilliamsJ DGeddesA M, (Eds), Chemotherapy 5, Penicillins and cephalosporins. Plenum Press, New York151.
7.
RozencweigMStaquetMKlasterskyJ (1976) Antibacterial activity and pharmacokinetics of bacampicillin and ampicillin. Clinical Pharmacology and Therapeutics19, 592.
8.
SimonCMalerczykVKlausM (1978) Absorption of bacampicillin and ampicillin and penetration into body fluids (skin blister fluid, saliva, tears) in healthy volunteers. Scandinavian Journal of Infectious Diseases, Supplementum (Stockholm)14, 228.
9.
SjövallJMagniLBerganT (1978) Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillin. Antimicrobial Agents and Chemotherapy13, 90.
